Results 121 to 130 of about 110,223 (206)

Effects of Propranolol on Patients with Complete Heart Block and Implanted Pacemakers [PDF]

open access: bronze, 1967
Ephraim Donoso   +5 more
openalex   +1 more source

Incidence of atrial fibrillation in patients with an insertable cardiac monitor and symptomatic heart failure

open access: yesESC Heart Failure, EarlyView.
Atrial fibrillation (AF) was observed in almost half of patients with insertable cardiac monitor and symptomatic heart failure (HF). One‐fourth of the patients had new onset AF and a higher rate of HF events compared with patients without AF. AF incidence was similar in HF patients with preserved versus reduced left ventricular ejection fraction ...
Muhammad Shahzeb Khan   +8 more
wiley   +1 more source

Motor cortical excitability and pre‐supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity

open access: yesJournal of Neuroscience Research, Volume 101, Issue 2, Page 263-277, February 2023., 2023
Substantia nigra (SN) hyperechogenicity, viewed with transcranial ultrasound, is a risk marker for Parkinson's disease. SN hyperechogenicity in healthy older adults is associated with changes in the excitability of specific motor cortical circuitry. These changes are unrelated to glutamate levels in the pre‐supplementary motor area (pre‐SMA).
Gabrielle Todd   +18 more
wiley   +1 more source

A SIMPLIFIED TECHNIQUE IN THE USE OF EXTERNAL CARDIAC PACEMAKERS

open access: bronze, 1964
Jay G. Silverman, Marvin S. Rosenberg
openalex   +1 more source

The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is a cardiomyopathy causing myocardial hypoperfusion and impaired cardiac mitochondrial function. Trimetazidine is an antianginal agent used in patients with stable angina pectoris, which improves cardiac contractility and mitochondrial function.
Bertil Thyrsted Ladefoged   +5 more
wiley   +1 more source

Real‐world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Large‐scale, real‐world data on early initiation of sacubitril/valsartan in patients newly diagnosed (de novo) with HF with reduced ejection fraction (HFrEF) are limited. We examined the effectiveness of sacubitril/valsartan versus angiotensin‐converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) on all‐cause and cause ...
Ankeet S. Bhatt   +6 more
wiley   +1 more source

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm. This study evaluated the effects of up‐titration of HF therapies, consisting of beta‐blockers, angiotensin‐converting‐enzyme inhibitors (ACEis ...
Arietje J.L. Zandijk   +6 more
wiley   +1 more source

Long‐term improvement in the appearance of hypertrophic scars following a single treatment with acoustic subcision—A single center proof‐of‐concept study

open access: yesLasers in Surgery and Medicine, Volume 54, Issue 10, Page 1251-1260, December 2022., 2022
Abstract Introduction and Objectives Fibrosis, including hypertrophic scar formation, is a pathological condition characterized by excessive production and accumulation of collagen, and loss of tissue architecture, in response to wound healing. Alterations in the extracellular matrix (ECM) biomechanical properties may be important in modulating ...
Brenda LaTowsky   +2 more
wiley   +1 more source

ELECTROCARDIOGRAPHIC STUDIES IN PATIENTS WITH AN ARTIFICIAL PACEMAKER [PDF]

open access: bronze, 1963
B Johansson   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy